16:01 Oct 04
Transgene Biotek Ltd.
Sector Diversified Consumer Services
Industry Healthcare Services
Transgene Biotek Ltd.
Industry Healthcare Services
16:01 Oct 04
Quality
0/100
Not Eligible
Valuation
5/100
Expensive Valuation
Technical
41/100
Technically Neutral
Strength
7
Weakness
5
Opportunity
3
Threats
1
-6.13 %
ROE %
-0.46 %
ROA %
0.00
EPS
1.41
BVPS
-282.22 %
Net Profit Margin
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM 2024 | ||
|---|---|---|---|---|---|---|
| Net Sales | 0.17 | 0.09 | 0.06 | 0.23 | 0.17 | |
| Operating Expenses + | 0.69 | 0.55 | 1.11 | 0.85 | 1.11 | |
| Raw Material | 0 | 0 | 0 | 0 | 0 | |
| Increase Decrease in Cost | 0 | -0.05 | 0 | 0 | 0 | |
| Other Manufacturing Expense | 0.06 | 0 | 0.07 | 0 | 0 | |
| Employee Cost | 0.25 | 0.29 | 0.3 | 0.31 | 0.32 | |
| Miscellaneous Expenses | 0.38 | 0.31 | 0.74 | 0.54 | 0.79 | |
| Operating Profit | -0.52 | -0.46 | -1.05 | -0.62 | -0.94 | |
| Other Income | 0.27 | 0.21 | 0.18 | 0.18 | 0.78 | |
| Depreciation | 9.91 | 9.92 | 4.95 | 0.09 | 0.08 | |
| Interest | 0.27 | 0.23 | 0.18 | 0.13 | 0.11 | |
| Profit before tax and exceptio.. | -10.43 | -10.4 | -6.01 | -0.66 | -0.35 | |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | |
| PBT | -10.43 | -10.4 | -6.01 | -0.66 | -0.35 | |
| Provision for Taxation | 0 | 0 | 0 | 0 | 0 | |
| Net Profit | -10.43 | -10.4 | -6.01 | -0.66 | -0.32 | |
| NET Profit after MI | -10.43 | -10.4 | -6.01 | -0.66 | -0.32 | |
| EPS | -1.38 | -1.37 | -0.79 | -0.09 | -0.05 | |
| Operating Profit Margin (%) | -305.88 | -511.11 | -1750 | -269.57 | -552.94 | |
| Net Profit Margin (%) | -6135.29 | -11555.56 | -10016.67 | -286.96 | -188.24 |
ShareHolding
Promoter
Public
All Data in Percentage (%)
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Promoter | 23.60 | 23.60 | 23.60 | 23.60 | 23.60 |
| FII | - | - | - | - | - |
| MF | - | - | - | - | - |
| Public | 76.40 | 76.40 | 76.40 | 76.40 | 76.40 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
